Evidence map›Paper›PMID 41629080›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026

[Towards precision diagnosis and treatment: interpretation of the ten highlights of the expert consensus on the diagnosis and treatment of hereditary hyperbilirubinemia (version 2025)].

W Hou, Z P Duan, S J Zheng

Abstract readEnglish Abstract
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

W HouThe First Department of the Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
Z P DuanThe Fourth Department of the Liver Disease Center,Beijing YouAn Hospital,Capital Medical University.
S J ZhengThe First Department of the Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.

Funding

Beijing Hospitals Authority's Ascent Plan DFL20241701Capital Health Development Research Project 2022-1-2182
6 · The paper itself

Abstract

To assist relevant clinicians specializing in liver diseases in making informed decisions regarding the diagnosis and treatment of hereditary hyperbilirubinemia, the Inherited and Metabolic Liver Disease Cooperative Group of the Hepatology Branch of the Chinese Medical Association has formulated the "Expert consensus on the diagnosis and treatment of hereditary hyperbilirubinemia". This consensus highlights ten key points across aspects such as epidemiology, pathogenesis, clinical features, laboratory tests, diagnosis, treatment, and monitoring, providing an in-depth analysis to assist clinicians in conveniently grasping the relevant content.

Indexed as

HyperbilirubinemiaPrecision MedicineConsensusConsensus Statements as TopicHumans

Identifiers

PMID41629080
PMCPMC12963867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.